Occurrence of hepatocellular carcinoma upon advanced liver fibrosis thirteen years after achieving sustained virological response to hepatitis C: how long surveillance should be maintained?

MeSH terms

• Antineoplastic Agents / therapeutic use
• Antiviral Agents / therapeutic use*
• Biomarkers / blood
• Biopsy
• Carcinoma, Hepatocellular / diagnosis
• Carcinoma, Hepatocellular / drug therapy
• Carcinoma, Hepatocellular / virology*
• Genotype
• Hepacivirus / drug effects*
• Hepacivirus / genetics
• Hepatitis C, Chronic / complications
• Hepatitis C, Chronic / diagnosis
• Hepatitis C, Chronic / drug therapy*
• Humans
• Liver Cirrhosis / diagnosis
• Liver Cirrhosis / virology*
• Liver Neoplasms / diagnosis
• Liver Neoplasms / drug therapy
• Liver Neoplasms / virology*
• Male
• Middle Aged
• Niacinamide / analogs & derivatives
• Niacinamide / therapeutic use
• Phenylurea Compounds / therapeutic use
• RNA, Viral / blood
• Severity of Illness Index
• Sorafenib
• Time Factors
• Tomography, X-Ray Computed
• Treatment Outcome
• Viral Load